Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Baudax Bio, Inc. (BXRX)

0.8347   -0.01 (-1.22%) 07-02 19:40
Open: 0.8327 Pre. Close: 0.845
High: 0.87 Low: 0.8091
Volume: 30,605 Market Cap: 5(M)
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMBA, which is in phase I clinical trial; BX3000, an NMBA reversal agent; and Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.87 - 0.88 0.88 - 0.88
Low: 0.8 - 0.8 0.8 - 0.81
Close: 0.83 - 0.84 0.84 - 0.84

Technical analysis

as of: 2022-07-01 4:20:39 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.02     One year: 1.2
Support: Support1: 0.75    Support2: 0.67
Resistance: Resistance1: 0.87    Resistance2: 1.02
Pivot: 0.77
Moving Average: MA(5): 0.83     MA(20): 0.76
MA(100): 1.71     MA(250): 10.42
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 79.3     %D(3): 80.2
RSI: RSI(14): 49.2
52-week: High: 26.6  Low: 0.39
Average Vol(K): 3-Month: 195 (K)  10-Days: 187 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ BXRX ] has closed below upper band by 19.8%. Bollinger Bands are 86.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 76 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 29 Jun 2022
Marpai (NASDAQ:MRAI) versus Baudax Bio (NASDAQ:BXRX) Head to Head Review - Defense World

Sun, 05 Jun 2022
Baudax Bio Announces Dosing of First Cohort in First-in-Man, Phase I Clinical Study Evaluating BX2000 - MyChesCo

Wed, 01 Jun 2022
Head-To-Head Contrast: Marpai (NASDAQ:MRAI) versus Baudax Bio (NASDAQ:BXRX) - Defense World

Wed, 18 May 2022
Health Care Sector Update for 05/18/2022: BXRX,ICCM,GHRS,PROC - Nasdaq

Tue, 17 May 2022
Baudax Bio Announces $2.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Yahoo Finance

Sat, 07 May 2022
Baudax Bio, Inc.'s (BXRX) CEO Gerri Henwood on Q1 2022 Results - Earnings Call Transcript - Seeking Alpha

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 6 (M)
% Held by Insiders 6.04e+006 (%)
% Held by Institutions 0.3 (%)
Shares Short 234 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -5.407e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -4
Return on Assets (ttm) 161.5
Return on Equity (ttm) -54.8
Qtrly Rev. Growth 1.3e+006
Gross Profit (p.s.) 55.99
Sales Per Share -177.29
EBITDA (p.s.) -673267
Qtrly Earnings Growth -6.6
Operating Cash Flow 0 (M)
Levered Free Cash Flow -48 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.01
Price to Cash Flow 1.1

Stock Dividends

Dividend 0
Forward Dividend 141440
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.